Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT00678886
Brief Title: Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 (DEFEND-1)

First Submitted : May 13, 2008
First Submitted that Met QC Criteria : May 15, 2008
First Posted : May 16, 2008 (Estimate)

Results First Submitted : July 19, 2017
Results First Submitted that Met QC Criteria : September 5, 2017
Results First Posted : October 3, 2017

Certification/Extension First Submitted : January 4, 2013
Certification/Extension First Submitted that Met QC Criteria : January 4, 2013
Certification/Extension First Posted : January 10, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : September 5, 2017
Last Update Posted : October 3, 2017